These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27383581)

  • 1. Relative impact of a patient blood management program on utilization of all three major blood components.
    Thakkar RN; Lee KH; Ness PM; Wintermeyer TL; Johnson DJ; Liu E; Rajprasad A; Knight AM; Wachter PA; Demski R; Frank SM
    Transfusion; 2016 Sep; 56(9):2212-20. PubMed ID: 27383581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763).
    Warner MA; Jambhekar NS; Saadeh S; Jacob EK; Kreuter JD; Mundell WC; Marquez A; Higgins AA; Madde NR; Hogan WJ; Kor DJ
    Transfusion; 2019 Sep; 59(9):2840-2848. PubMed ID: 31222775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization.
    Zuckerberg GS; Scott AV; Wasey JO; Wick EC; Pawlik TM; Ness PM; Patel ND; Resar LM; Frank SM
    Transfusion; 2015 Jul; 55(7):1628-36. PubMed ID: 25646579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program.
    Leahy MF; Trentino KM; May C; Swain SG; Chuah H; Farmer SL
    Transfusion; 2017 Sep; 57(9):2189-2196. PubMed ID: 28671296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey.
    Whitaker B; Rajbhandary S; Kleinman S; Harris A; Kamani N
    Transfusion; 2016 Sep; 56(9):2173-83. PubMed ID: 27301995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction.
    Sarode R; Refaai MA; Matevosyan K; Burner JD; Hampton S; Rutherford C
    Transfusion; 2010 Feb; 50(2):487-92. PubMed ID: 19804569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals.
    Leahy MF; Hofmann A; Towler S; Trentino KM; Burrows SA; Swain SG; Hamdorf J; Gallagher T; Koay A; Geelhoed GC; Farmer SL
    Transfusion; 2017 Jun; 57(6):1347-1358. PubMed ID: 28150313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient blood management in cardiac surgery results in fewer transfusions and better outcome.
    Gross I; Seifert B; Hofmann A; Spahn DR
    Transfusion; 2015 May; 55(5):1075-81. PubMed ID: 25565302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients.
    Butler CE; Noel S; Hibbs SP; Miles D; Staves J; Mohaghegh P; Altmann P; Curnow E; Murphy MF
    Transfusion; 2015 Aug; 55(8):1964-71. PubMed ID: 25906831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival.
    Pidcoke HF; Aden JK; Mora AG; Borgman MA; Spinella PC; Dubick MA; Blackbourne LH; Cap AP
    J Trauma Acute Care Surg; 2012 Dec; 73(6 Suppl 5):S445-52. PubMed ID: 23192068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of blood utilization in children and adolescents in a German university hospital.
    Zimmermann R; Handtrack D; Zingsem J; Weisbach V; Neidhardt B; Glaser A; Eckstein R
    Transfus Med; 1998 Sep; 8(3):185-94. PubMed ID: 9800290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.
    Osselaer JC; Doyen C; Defoin L; Debry C; Goffaux M; Messe N; Van Hooydonk M; Bosly A; Lin JS; Lin L; Corash L
    Transfusion; 2009 Jul; 49(7):1412-22. PubMed ID: 19389022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-unit transfusions and hemoglobin trigger: relative impact on red cell utilization.
    Yang WW; Thakkar RN; Gehrie EA; Chen W; Frank SM
    Transfusion; 2017 May; 57(5):1163-1170. PubMed ID: 28164305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence.
    Henrichs KF; Howk N; Masel DS; Thayer M; Refaai MA; Kirkley SA; Heal JM; Blumberg N
    Transfusion; 2012 Mar; 52(3):635-40. PubMed ID: 21895675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restrictive blood transfusion practices are associated with improved patient outcomes.
    Goodnough LT; Maggio P; Hadhazy E; Shieh L; Hernandez-Boussard T; Khari P; Shah N
    Transfusion; 2014 Oct; 54(10 Pt 2):2753-9. PubMed ID: 24995770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion protocol for implantation and explantation of cardiac devices in an academic medical center.
    Bartley AN; Redford DT; Berg MP
    ASAIO J; 2007; 53(3):320-3. PubMed ID: 17515722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The success of our patient blood management program depended on an institution-wide change in transfusion practices.
    Oliver JC; Griffin RL; Hannon T; Marques MB
    Transfusion; 2014 Oct; 54(10 Pt 2):2617-24. PubMed ID: 24410741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness evaluation of the PROPPR trial transfusion protocols.
    Callcut RA; Simpson KN; Baraniuk S; Fox EE; Tilley BC; Holcomb JB;
    Transfusion; 2020 May; 60(5):922-931. PubMed ID: 32358836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.